Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
about
Biomarkers to guide clinical therapeutics in rheumatology?Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis.Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register.Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseasesAntibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts.Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis.Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort.Preclinical Rheumatoid Arthritis: Progress Toward Prevention.Pre-symptomatic autoimmunity in rheumatoid arthritis: when does the disease start?Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid Arthritis.The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis.Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls.Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis.Biomarkers in connective tissue diseases.Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements:A randomized controlled trial.The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anti-citrullinated protein antibody positive population.The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.Editorial: Anti-Citrullinated Protein Antibody, Anti-Carbamylated Protein Antibody, and Rheumatoid Arthritis: Azurophilic Granules Sing the Blues.Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.[Treat to target and personalized medicine (precision medicine)].Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients
P2860
Q28080053-54430577-738C-41AC-B5CB-558FE1D2CD17Q36082681-1272FFA4-CFFA-4390-AE45-506AD10EC8E2Q36107157-C35DE709-10FA-418D-90E7-4D031EE9CA2BQ36565997-03021ADB-4247-4177-A3CF-74C163CAE396Q36603271-8608AAA0-645F-44CE-A2CF-9550FF278662Q36968730-05F24734-8BF3-4C63-B73B-45774333C4A2Q37156391-03BAC80B-0AC4-415C-8900-31B4EDA13ACEQ37442781-73D3C800-7F83-4667-B005-A6C3DD22728CQ37470470-12114A97-D8B3-4E09-93A7-F63F0EB2C666Q37727141-DEDD3D95-EC3B-4979-8753-78E1307F958EQ38602504-EC1E401D-2426-4CBE-96A7-B24D968EE6DFQ38712937-B07F95F8-FA7A-4FCD-932A-4D8019D5F95CQ38880624-6E2194AA-7FB7-4AAA-9CA8-0B49FFEEDB4BQ39139958-134464BF-1D43-475D-9CCA-A273ABB10F11Q39432157-7146777B-022C-4783-9EE4-5D04427E1305Q40117130-6157AFB7-467C-4FB4-9804-D9A2C0140E60Q41431357-DF43DD54-8325-4673-96A7-A1FBE46CA4D3Q41697121-CF5ED78D-FDEB-4670-9D0D-181493A0D9DEQ42371035-714FAF86-742F-47A0-B666-3F49F2873F03Q43158822-21EAEFC5-8BDF-4E1F-98A8-E3FC1A29F659Q46640361-D423E14F-C1E2-43F6-9311-91347511B3B4Q47129849-0CE45B29-4476-4EFF-BEE0-CA3ACCE74AB0Q47314399-E1B74FD8-AD15-4448-BD4A-EB8711334C7FQ47314784-47AE277C-7BED-46CB-82E1-09A881644003Q47656604-BC492E76-4B6C-4329-B9AE-1FD409019C20Q47714795-69A598C1-0A89-4045-9DA7-E72B8DEE4740Q47884810-E5BBCC18-BE36-45C3-BFEC-207BC5C5F49EQ51063652-147D70D2-7D4F-44A4-8343-B4D3B4E1ED6DQ52850371-64575E39-8415-4CC3-8B07-07188D41BEF2Q58771663-6C050CB8-8966-465D-998B-2DDC1BD4BF67
P2860
Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@ast
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@en
type
label
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@ast
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@en
prefLabel
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@ast
Anti-carbamylated protein anti ...... ted with its future diagnosis.
@en
P2093
P2860
P356
P1476
Anti-carbamylated protein anti ...... ated with its future diagnosis
@en
P2093
Gary O Zerbe
Jason R Kolfenbach
Jess D Edison
Jill M Norris
Kevin D Deane
M Kristen Demoruelle
Ryan W Gan
Tom W J Huizinga
V Michael Holers
P2860
P304
P356
10.3899/JRHEUM.140767
P407
P577
2015-01-15T00:00:00Z